Burning Rock Biotech (BNR) Asset Utilization Ratio: 2021-2025
Historic Asset Utilization Ratio for Burning Rock Biotech (BNR) over the last 4 years, with Mar 2025 value amounting to 0.16.
- Burning Rock Biotech's Asset Utilization Ratio fell 61.49% to 0.16 in Q1 2025 from the same period last year, while for Mar 2025 it was 0.16, marking a year-over-year decrease of 61.49%. This contributed to the annual value of 0.53 for FY2024, which is 31.31% up from last year.
- Latest data reveals that Burning Rock Biotech reported Asset Utilization Ratio of 0.16 as of Q1 2025, which was down 70.37% from 0.54 recorded in Q4 2024.
- In the past 5 years, Burning Rock Biotech's Asset Utilization Ratio registered a high of 0.54 during Q4 2024, and its lowest value of -2.03 during Q3 2024.
- Its 3-year average for Asset Utilization Ratio is -0.10, with a median of -0.01 in 2023.
- The largest annual percentage gain for Burning Rock Biotech's Asset Utilization Ratio in the last 5 years was 2,793.82% (2024), contrasted with its biggest fall of 5,558.96% (2024).
- Over the past 5 years, Burning Rock Biotech's Asset Utilization Ratio (Quarterly) stood at 0.22 in 2021, then plummeted by 168.07% to -0.15 in 2022, then soared by 52.53% to -0.07 in 2023, then spiked by 869.97% to 0.54 in 2024, then slumped by 61.49% to 0.16 in 2025.
- Its Asset Utilization Ratio stands at 0.16 for Q1 2025, versus 0.54 for Q4 2024 and -2.03 for Q3 2024.